Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitorsRoberto Pellicciari, Emidio Camaioni, Gabriele Costantino, et al.
Neuropharmacology|January 28, 2015
Interplay between histone acetylation/deacetylation and poly(ADP-ribosyl)ation in the development of ischemic tolerance in vitroElisabetta Gerace, Elisa Landucci, Tania Scartabelli, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 16, 2007
Amatoxin poisoning: a 15-year retrospective analysis and follow-up evaluation of 105 patientsLucia Giannini, Alfredo Vannacci, Andrea Missanelli, et al.
The European Journal of Neuroscience|July 6, 2007
Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic toleranceClaudia G Werner, Tania Scartabelli, Tristano Pancani, et al.
The European Journal of Neuroscience|May 30, 2012
Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic toleranceElisabetta Gerace, Tania Scartabelli, Laura Formentini, et al.
Toxicology Letters|March 12, 2003
Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damageElena Meli, Marilena Pangallo, Roberto Baronti, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 22, 2012
Ischemic neuroprotection by TRPV1 receptor-induced hypothermiaMirko Muzzi, Roberta Felici, Leonardo Cavone, et al.
Frontiers in Pharmacology|June 6, 2019
Effects of PARP-1 Deficiency and Histamine H4 Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in MiceMariaconcetta Durante, Silvia Sgambellone, Cecilia Lanzi, et al.
Pageof 7